Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:37 AM
Ignite Modification Date:
2025-12-25 @ 2:37 AM
NCT ID:
NCT01085734
Eligibility Criteria:
Inclusion Criteria:
* male or female age 18 years or older
* Branch retinal vein occlusion or central retinal vein occlusion of less than one year duration
* Best correct visual acuity of greater than 24 and less than 80
* Presence of macular edema defined as OCT central subfield thickness of \>250
Exclusion Criteria:
* intravitreal anti-VEGF treatment in study eye within six weeks of baseline
* intravitreal steroid treatment in the study eye within eight weeks of baseline visit
* PRP in the study eye within 4 month of baseline visit
* Active iris neovascularization in study eye
* Uncontrolled systemic disease
* Known history of IOP elevation in response to corticosteroid treatment that is not controlled on 2 glaucoma medications
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01085734
Study Brief:
Protocol Section:
NCT01085734